Cart
sales@molnova.com
VUN65671
CAS No. 2479465-67-1
VUN65671( )
Catalog No. M28888 CAS No. 2479465-67-1
VUN65671is a Potent Entry Inhibitor of Ebola and Marburg Virus Infections. VUN65671 was reported in Journal of Medicinal Chemistry (2020), 63(13), 7211-7225. This product has no formal name at the moment.
VUN65671is a Potent Entry Inhibitor of Ebola and Marburg Virus Infections. VUN65671 was reported in Journal of Medicinal Chemistry (2020), 63(13), 7211-7225. This product has no formal name at the moment.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 133 | In Stock |
|
| 10MG | 220 | In Stock |
|
| 25MG | 404 | In Stock |
|
| 50MG | 657 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVUN65671
-
NoteResearch use only, not for human use.
-
Brief DescriptionVUN65671is a Potent Entry Inhibitor of Ebola and Marburg Virus Infections. VUN65671 was reported in Journal of Medicinal Chemistry (2020), 63(13), 7211-7225. This product has no formal name at the moment.
-
DescriptionVUN65671is a Potent Entry Inhibitor of Ebola and Marburg Virus Infections. VUN65671 was reported in Journal of Medicinal Chemistry (2020), 63(13), 7211-7225. This product has no formal name at the moment.
-
In VitroEBOV/MARV-IN-1 (12.5 μM; 48 h) inhibits HIV/EBOV-GP (EC50=12 nM) and HIV/MARV-GP (EC50=180 nM) pseudotype virus in A549 cells containing a luciferase reporter gene, with low cytotoxicity (SI =2088).
-
In Vivo
-
Synonyms
-
PathwayOthers
-
TargetOther Targets
-
RecptorSGLT2
-
Research Area
-
Indication
Chemical Information
-
CAS Number2479465-67-1
-
Formula Weight461.52
-
Molecular FormulaC25H30F3N3O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (216.68 mM)
-
SMILESCC1CCN(CC1)C1=CC=C(NC(=O)C2=CC=C(CN3CCOCC3)C=C2)C=C1C(F)(F)F
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hussey EK, et al. Multiple-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy overweight and obese subjects: a randomized double-blind study. J Clin Pharmacol. 2010 Jun;50(6):636-46.
molnova catalog
related products
-
Raloxifene
Raloxifene is a selective oestrogen receptor modulator. It has effects on bone and breast cancer and cardiovascular disease risk.
-
1-alpha-H,5-alpha H-...
1αH,5αH-guaia-6-ene-4β,10β-diol is a natural product.
-
5(6)-Carboxyfluoresc...
5(6)-Carboxyfluorescein contains a carboxylic acid that can be used to react with primary amines via carbodiimide activation of the carboxylic acid.
